Cargando…
Action Sites and Clinical Application of HIF-1α Inhibitors
Hypoxia-inducible factor-1α (HIF-1α) is widely distributed in human cells, and it can form different signaling pathways with various upstream and downstream proteins, mediate hypoxia signals, regulate cells to produce a series of compensatory responses to hypoxia, and play an important role in the p...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9182161/ https://www.ncbi.nlm.nih.gov/pubmed/35684364 http://dx.doi.org/10.3390/molecules27113426 |
_version_ | 1784723966699503616 |
---|---|
author | Xu, Renfeng Wang, Fan Yang, Hongqin Wang, Zhengchao |
author_facet | Xu, Renfeng Wang, Fan Yang, Hongqin Wang, Zhengchao |
author_sort | Xu, Renfeng |
collection | PubMed |
description | Hypoxia-inducible factor-1α (HIF-1α) is widely distributed in human cells, and it can form different signaling pathways with various upstream and downstream proteins, mediate hypoxia signals, regulate cells to produce a series of compensatory responses to hypoxia, and play an important role in the physiological and pathological processes of the body, so it is a focus of biomedical research. In recent years, various types of HIF-1α inhibitors have been designed and synthesized and are expected to become a new class of drugs for the treatment of diseases such as tumors, leukemia, diabetes, and ischemic diseases. This article mainly reviews the structure and functional regulation of HIF-1α, the modes of action of HIF-1α inhibitors, and the application of HIF-1α inhibitors during the treatment of diseases. |
format | Online Article Text |
id | pubmed-9182161 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91821612022-06-10 Action Sites and Clinical Application of HIF-1α Inhibitors Xu, Renfeng Wang, Fan Yang, Hongqin Wang, Zhengchao Molecules Review Hypoxia-inducible factor-1α (HIF-1α) is widely distributed in human cells, and it can form different signaling pathways with various upstream and downstream proteins, mediate hypoxia signals, regulate cells to produce a series of compensatory responses to hypoxia, and play an important role in the physiological and pathological processes of the body, so it is a focus of biomedical research. In recent years, various types of HIF-1α inhibitors have been designed and synthesized and are expected to become a new class of drugs for the treatment of diseases such as tumors, leukemia, diabetes, and ischemic diseases. This article mainly reviews the structure and functional regulation of HIF-1α, the modes of action of HIF-1α inhibitors, and the application of HIF-1α inhibitors during the treatment of diseases. MDPI 2022-05-26 /pmc/articles/PMC9182161/ /pubmed/35684364 http://dx.doi.org/10.3390/molecules27113426 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Xu, Renfeng Wang, Fan Yang, Hongqin Wang, Zhengchao Action Sites and Clinical Application of HIF-1α Inhibitors |
title | Action Sites and Clinical Application of HIF-1α Inhibitors |
title_full | Action Sites and Clinical Application of HIF-1α Inhibitors |
title_fullStr | Action Sites and Clinical Application of HIF-1α Inhibitors |
title_full_unstemmed | Action Sites and Clinical Application of HIF-1α Inhibitors |
title_short | Action Sites and Clinical Application of HIF-1α Inhibitors |
title_sort | action sites and clinical application of hif-1α inhibitors |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9182161/ https://www.ncbi.nlm.nih.gov/pubmed/35684364 http://dx.doi.org/10.3390/molecules27113426 |
work_keys_str_mv | AT xurenfeng actionsitesandclinicalapplicationofhif1ainhibitors AT wangfan actionsitesandclinicalapplicationofhif1ainhibitors AT yanghongqin actionsitesandclinicalapplicationofhif1ainhibitors AT wangzhengchao actionsitesandclinicalapplicationofhif1ainhibitors |